Evidence map›Paper›PMID 22513779›Full record

ArticleThe Journal of investigative dermatology2012

Exons 5-15 of kazrin are dispensable for murine epidermal morphogenesis and homeostasis.

Mariya K Chhatriwala, Sara Cipolat, Lisa M Sevilla, Rachida Nachat, Fiona M Watt

Open access · hybridAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Mariya K ChhatriwalaWellcome Trust Centre for Stem Cell Research, Cambridge University, Cambridge, UK.
Sara Cipolat
Lisa M Sevilla
Rachida Nachat
Fiona M Watt
Instituto de Biomedicina de Valencia · ESUniversité Clermont Auvergne · FRUniversity of Cambridge · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Cancer Research UKMedical Research CouncilWellcome Trust 079249
6 · The paper itself

Abstract

Kazrin binds to periplakin and ARVCF catenin, and regulates adhesion and differentiation of cultured human keratinocytes. To explore kazrin function in vivo, we generated a kazrin gene-trap mouse in which only exons 1-4 were expressed, fused to β-galactosidase. On transient transfection, the protein encoded by exons 1-4 did not enter the nucleus, but did cause keratinocyte shape changes. The mice had no obvious defects in skin development or homeostasis, and periplakin and desmoplakin localization was normal. Expression of the kazrin-β-galactosidase fusion protein faithfully reported endogenous kazrin expression. Kazrin was not expressed in embryonic epidermis and was first detected at postnatal day 1. In adult mice, epidermal kazrin expression was less widespread than in humans and Xenopus, being confined to the bulb of anagen hair follicles, the infundibulum, and parakeratotic tail epidermis. In anagen bulbs, kazrin was expressed by a band of cells with elongated morphology and low desmoplakin levels, suggesting a role in morphogenetic cell movements. We conclude that exons 5-15 of kazrin, encoding the nuclear localization signal and C-terminal domain, are not required for epidermal development and function. The previously reported role of kazrin in regulating cell shape appears to reside within the N-terminal coiled-coil domain encoded by exons 1-4.

Indexed as

Epidermal CellsExonsAnimalsCarrier ProteinsCell NucleusCytoskeletal ProteinsEpidermisGene Expression RegulationHomeostasisHumansIntracellular Signaling Peptides and ProteinsKeratinocytesMembrane ProteinsMiceModels, GeneticProtein BindingCarrier ProteinsCytoskeletal ProteinsIntracellular Signaling Peptides and ProteinsKAZN protein, humanKazn protein, mouseMembrane ProteinsRecombinant ProteinsRNA, Small Interfering

Identifiers

PMID22513779
PMCPMC3398255
OpenAlexW2017517049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.